A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats

• Hidemichi Takai,
• Yoichi Sunagawa,
• Masafumi Funamoto,
• Kana Shimizu,
• Satoshi Shimizu,
• Yasufumi Katanasaka,
• Yusuke Miyazaki,
• Atsusi Imaizumi,
• Tadashi Hashimoto,
• Hiromichi Wada,
• Koji Hasegawa,
• Tatsuya Morimoto

Affiliations

Hidemichi Takai

University of Shizuoka, Shizuoka, Japan

Yoichi Sunagawa

University of Shizuoka, Shizuoka, Japan; Kyoto Medical Center, Kyoto, Japan; Shizuoka General Hosipital, Shizuoka, Japan

Masafumi Funamoto

University of Shizuoka, Shizuoka, Japan; Kyoto Medical Center, Kyoto, Japan

Kana Shimizu

University of Shizuoka, Shizuoka, Japan; Kyoto Medical Center, Kyoto, Japan

Satoshi Shimizu

University of Shizuoka, Shizuoka, Japan; Kyoto Medical Center, Kyoto, Japan

Yasufumi Katanasaka

University of Shizuoka, Shizuoka, Japan; Kyoto Medical Center, Kyoto, Japan; Shizuoka General Hosipital, Shizuoka, Japan

Yusuke Miyazaki

University of Shizuoka, Shizuoka, Japan; Kyoto Medical Center, Kyoto, Japan; Shizuoka General Hosipital, Shizuoka, Japan

Atsusi Imaizumi

Therabiopharma Inc, Japan

Tadashi Hashimoto

Therabiopharma Inc, Japan

Hiromichi Wada

Kyoto Medical Center, Kyoto, Japan

Koji Hasegawa

University of Shizuoka, Shizuoka, Japan; Kyoto Medical Center, Kyoto, Japan

Tatsuya Morimoto

University of Shizuoka, Shizuoka, Japan; Kyoto Medical Center, Kyoto, Japan; Shizuoka General Hosipital, Shizuoka, Japan